Results
77
Companies which have announced upcoming dividend payments.
77 companies
Ono Pharmaceutical
Market Cap: JP¥787.2b
Produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide.
4528
JP¥1,676.00
7D
2.9%
1Y
-32.1%
Takeda Pharmaceutical
Market Cap: JP¥7.0t
Engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan and internationally.
4502
JP¥4,461.00
7D
-0.5%
1Y
4.4%
Novartis
Market Cap: CHF 189.0b
Engages in the research, development, manufacture, distribution, marketing, and sale of pharmaceutical medicines in Switzerland and internationally.
NOVN
CHF 96.31
7D
-3.7%
1Y
10.5%
Merck
Market Cap: US$240.6b
Operates as a healthcare company worldwide.
MRK
US$94.73
7D
2.3%
1Y
-22.8%
JW Holdings
Market Cap: ₩214.0b
Operates as a healthcare company in South Korea, the United States, Japan, China, and internationally.
A096760
₩3,025.00
7D
-2.3%
1Y
-7.1%
Linical
Market Cap: JP¥7.6b
Provides drug development services primarily in the areas of oncology and central nervous system to pharmaceutical companies worldwide.
2183
JP¥336.00
7D
2.1%
1Y
-15.4%
Hikma Pharmaceuticals
Market Cap: UK£4.7b
Develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products.
HIK
UK£20.72
7D
-3.5%
1Y
10.5%
Merck KGaA
Market Cap: €58.3b
Operates as a science and technology company in Germany.
MRK
€134.25
7D
-2.1%
1Y
-16.1%
Santen Pharmaceutical
Market Cap: JP¥479.0b
Engages in the research and development, manufacture, and marketing of pharmaceuticals and medical devices in Japan and internationally.
4536
JP¥1,424.00
7D
-0.7%
1Y
-1.4%
TTY Biopharm
Market Cap: NT$20.0b
Engages in the development and sale of pharmaceutical and chemical drugs in Taiwan and internationally.
4105
NT$80.50
7D
-0.1%
1Y
-1.1%
Shionogi
Market Cap: JP¥1.9t
Engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan.
4507
JP¥2,251.00
7D
-3.0%
1Y
-14.4%
Astena Holdings
Market Cap: JP¥18.0b
Manufactures and sells medicine-related products in Japan.
8095
JP¥448.00
7D
1.1%
1Y
-5.5%
Zeria Pharmaceutical
Market Cap: JP¥99.0b
Manufactures, sells, imports, and exports pharmaceuticals, non-pharmaceutical products, veterinary pharmaceuticals, agricultural chemicals, industrial chemicals, and reagents in Japan and internationally.
4559
JP¥2,247.00
7D
2.2%
1Y
6.6%
Kaken Pharmaceutical
Market Cap: JP¥182.7b
Produces, markets, and sells medical products, medical devices, and agrochemicals in Japan and internationally.
4521
JP¥4,823.00
7D
0.4%
1Y
37.0%
Organon
Market Cap: US$4.1b
Develops and delivers health solutions through prescription therapies and medical devices in the United States, Europe, Canada, Japan, rest of the Asia Pacific, Latin America, the Middle East, Russia, Africa, and internationally.
OGN
US$15.60
7D
9.2%
1Y
-14.6%
Sawai Group Holdings
Market Cap: JP¥240.8b
Together with subsidiaries, engages in the research and development, manufacturing, and marketing of generic pharmaceuticals.
4887
JP¥2,086.00
7D
-0.9%
1Y
0.2%
Panchsheel Organics
Market Cap: ₹1.6b
Engages in the manufacture and trading of bulk drugs and intermediates in India and internationally.
531726
₹137.05
7D
-12.3%
1Y
-29.9%
Vita Life Sciences
Market Cap: AU$102.9m
A healthcare company, engages in formulating, packaging, distributing, and selling vitamins and supplements in Australia, Singapore, Malaysia, Thailand, Vietnam, Indonesia, and China.
VLS
AU$1.85
7D
1.6%
1Y
-17.8%
AbbVie
Market Cap: US$382.5b
A research-based biopharmaceutical company, engages in the research and development, manufacture, commercialization, and sale of medicines and therapies worldwide.
ABBV
US$213.59
7D
2.8%
1Y
18.1%
Mega Lifesciences
Market Cap: ฿27.9b
Manufactures and sells health food supplements, prescription pharmaceutical products, over-the-counter products, herbal products, vitamins, and fast-moving consumer goods in Southeast Asia and Sub-Saharan Africa.
MEGA
฿32.00
7D
-3.8%
1Y
-22.4%
Kissei Pharmaceutical
Market Cap: JP¥158.4b
Researches, develops, manufactures, and sells pharmaceutical products primarily in Japan.
4547
JP¥3,700.00
7D
0%
1Y
0.3%
Eisai
Market Cap: JP¥1.2t
Engages in the research and development, manufacture, sale, and import and export of pharmaceuticals in Japan.
4523
JP¥4,268.00
7D
0.2%
1Y
-34.2%
Gerresheimer
Market Cap: €2.7b
Manufactures and sells medicine packaging, drug delivery devices, and solutions in Germany and internationally.
GXI
€79.45
7D
-1.5%
1Y
-23.1%
Roche Holding
Market Cap: CHF 237.6b
Engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand.
ROG
CHF 307.30
7D
1.4%
1Y
27.5%
Orion Oyj
Market Cap: €7.4b
Develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally.
ORNBV
€53.92
7D
-1.1%
1Y
50.2%
Bristol-Myers Squibb
Market Cap: US$128.1b
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide.
BMY
US$61.51
7D
3.5%
1Y
13.1%
Nippon Shinyaku
Market Cap: JP¥269.9b
Manufactures and sells pharmaceuticals and foodstuffs in Japan and internationally.
4516
JP¥4,005.00
7D
0.03%
1Y
-10.8%
JW Lifescience
Market Cap: ₩170.3b
Provides national infusion solutions in South Korea and internationally.
A234080
₩11,000.00
7D
3.9%
1Y
-12.9%
JCR Pharmaceuticals
Market Cap: JP¥62.0b
Engages in the research, development, manufacture, import and export, and sale of pharmaceutical products, regenerative medicines, and drug substances in Japan.
4552
JP¥509.00
7D
-3.6%
1Y
-42.7%
Astellas Pharma
Market Cap: JP¥2.6t
Manufactures, markets, and imports and exports pharmaceuticals in Japan and internationally.
4503
JP¥1,458.00
7D
-0.8%
1Y
-7.9%
Hisamitsu Pharmaceutical
Market Cap: JP¥292.0b
Manufactures and sells pharmaceuticals in Japan.
4530
JP¥4,003.00
7D
-3.7%
1Y
5.3%
Kyowa Kirin
Market Cap: JP¥1.2t
Engages in the research, development, manufacturing, marketing, and import/export of pharmaceuticals for oncology, nephrology, central nervous system, and immunology therapeutic areas in Japan, the United States, rest of the Americas, Europe, Asia, and internationally.
4151
JP¥2,201.00
7D
1.0%
1Y
-22.1%
CSL
Market Cap: AU$121.2b
Researches, develops, manufactures, markets, and distributes biopharmaceutical and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally.
CSL
AU$250.37
7D
-5.3%
1Y
-10.6%
Zoetis
Market Cap: US$76.9b
Engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health products in the United States and internationally.
ZTS
US$164.39
7D
-3.2%
1Y
-9.4%
Sam-A Pharm
Market Cap: ₩98.1b
Operates as a pharmaceutical company in South Korea.
A009300
₩16,080.00
7D
-1.2%
1Y
-2.2%
Tsumura
Market Cap: JP¥335.7b
Manufactures and sells pharmaceutical products from crude drugs derived from plants and other natural products in Japan and internationally.
4540
JP¥4,420.00
7D
2.8%
1Y
19.8%